title: Oral contraceptive administration prevents relapse of periodic psychosis with hyperprolactinemia.
authors.forename: Kotaro
authors.initials: K
authors.lastname: Otsuka
authors.forename: Akio
authors.initials: A
authors.lastname: Sakai
authors.forename: Toshio
authors.initials: T
authors.lastname: Okudera
authors.forename: Eri
authors.initials: E
authors.lastname: Shibata
authors.forename: Koichi
authors.initials: K
authors.lastname: Matoh
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kawamura
mesh_terms: D000328:Adult; D018692:Antimanic Agents / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000517:prevention & control* / Q000523:psychology; D008597:Menstrual Cycle / Q000502:physiology / Q000523:psychology; D011618:Psychotic Disorders / Q000150:complications / Q000517:prevention & control* / Q000523:psychology; D055502:Secondary Prevention; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D018692:Antimanic Agents; D003278:Contraceptives, Oral, Hormonal; D014635:Valproic Acid